Frazier Life Sciences Management L.P. lifted its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 214.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,667,203 shares of the company’s stock after buying an additional 1,818,181 shares during the […]